Health Futures

is a government relations, public policy and strategic development firm representing clients in the dynamic new world of predictive and personalized health care. We specialize in navigating the labyrinth of legislators, regulators, health care providers, patient advocates, third-party payers, and journalists who will ultimately determine if innovation succeeds or fails.

Practice Areas Image

Public health, research and patient advocacy

The federal government continues to play a dominant role in setting the tone and direction of public health policy. Decisions made in Congress and at federal agencies guide medical and health services research priorities at public and private research institutions; determine funding for disease prevention, treatment and health promotion; and provide direct support for needed patient and family services. CRD Associates has helped patient groups, medical societies and pharmaceutical companies draw attention and resources to the issues that matter most to them.

  • Working with the Cooley’s Anemia Foundation, CRD Associates helped to devise a strategy enabling this group of patient advocates to play an integral role in support of a new drug application for a treatment that is critically important to their patients’ survival. The plan involved multiple meetings with Food and Drug Administration (FDA) officials reviewing the applications, and presenting expert witnesses at an FDA advisory committee hearing. The drug was recommended for approval by the advisory committee and subsequently approved by the FDA.
  • Noting the mounting number of military personnel who suffer extremity war injuries, the American Academy of Orthopaedic Surgeons sought CRD Associates’ help with building a Department of Defense-funded program dedicated to these types of injuries.  Based on our knowledge of operations at the Department of Defense and the service branches, our team developed a strategic plan of action to raise the visibility of this issue and build support in the military hierarchy and in Congress. As a result, a new, dedicated peer-review research program was created and, thus far, $182 million has been appropriated by Congress.
  • The American Association for the Study of Liver Diseases partnered with CRD Associates to devise a plan to mobilize government agencies to stem the rapid increase in new cases of viral hepatitis and related diseases. CRD Associates conceived a strategy that helped convince officials at the HHS and the CDC to develop a Viral Hepatitis Action Plan. Released in May 2011, the plan, combined with newly-approved drug treatments, will move viral hepatitis into a new level of public attention, treatment and cures. The plan leverages opportunities to improve coordination of viral hepatitis activities across the U.S. Public Health Service; sets priorities for achieving public health and primary care infrastructure needs; and provides a framework for government-wide coordination in viral hepatitis prevention and treatment.
  • On behalf of AcademyHealth, the preeminent professional society for health services researchers and health policy analysts, CRD Associates represents the Friends of AHRQ and the Friends of NCHS—voluntary alliances of over 200 organizations that advocate for increased funding for the Agency for Healthcare Research and Quality (AHRQ) and the National Center for Health Statistics (NCHS). Over the past seven years, CRD Associates employed a variety of strategies and tactics—including congressional briefings, national grassroots campaigns and agency outreach activities—that have led to a 30 percent increase in both agencies’ operating budgets. As demand grew from all sectors of the health care system for more comparative clinical research, CRD Associates played a role in crafting the comparative effectiveness research program first launched in the 2009 economic stimulus bill. The firm is currently working with AcademyHealth on implementation of the Patient-Centered Outcomes Research Institute (PCORI).
  • While in its formative years, the Alzheimer’s Association sought to draw attention and resources to growing epidemic of Alzheimer’s in an aging society. Through a combination of careful strategic planning, direct lobbying and well-coordinated grassroots campaigns, CRD Associates helped the Alzheimer’s Association build and sustain an infrastructure of federal programs that support research, patient services and caregiver assistance. NIH now allocates more than $450 million each year for Alzheimer research; the Administration on Aging annually awards grants to states that provide innovative health and long-term care services to families caring for Alzheimer patients; and the CDC supports community-based prevention and surveillance activities related to Alzheimer’s disease.